NuCana (NCNA) Interest Expenses (2025)

NuCana's (NCNA) quarterly Interest Expenses came in at $33.6 million in Q4 2025, up 299.42% quarter-over-quarter from -$16.9 million in Q2 2025.

NuCana (NCNA) Interest Expenses (2025) Analysis & Trends

NuCana has disclosed Interest Expenses across 1 years of filings, most recently posting $33.6 million for Q4 2025.

Interest Expenses for Q4 2025 came in at $33.6 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $16.8 million (changed N/A YoY), and the FY2025 annual result was $16.7 million, changed N/A from the prior year.
Interest Expenses came in at $33.6 million for Q4 2025 at NuCana, up from -$16.9 million in the prior quarter.
In the past five years, Interest Expenses ranged from a high of $33.6 million in Q4 2025 to a low of -$16.9 million in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Interest Expense (Qtr)
1	Alterity Therapeutics	723,416.35 Bn	723,416.32 Bn	-	-
2	Belite Bio	57,340.00 Bn	57,340.00 Bn	-	-
3	Quantum Biopharma	19,125.08 Bn	19,125.08 Bn	-	-
4	Legend Biotech	3,262.00 Bn	3,261.71 Bn	242.10 Mn	-5.50 Mn
5	Akari Therapeutics	1,789.67 Bn	1,789.67 Bn	-	61,000.00
6	Evaxion A	1,480.39 Bn	1,480.37 Bn	-	-332,000.00
7	Psyence Biomedical	241.78 Bn	241.78 Bn	-	-2,753.00
8	Vertex Pharmaceuticals	113.54 Bn	106.29 Bn	2.59 Bn	-
9	Abivax	94.26 Bn	94.26 Bn	-	-5.58 Mn
10	NuCana	29.13 Bn	29.13 Bn	-	33.65 Mn

Download Data